U.S. patent application number 11/133642 was filed with the patent office on 2005-10-06 for method of providing cosmetic/medical therapy.
Invention is credited to Orton, Kevin R..
Application Number | 20050217682 11/133642 |
Document ID | / |
Family ID | 46281621 |
Filed Date | 2005-10-06 |
United States Patent
Application |
20050217682 |
Kind Code |
A1 |
Orton, Kevin R. |
October 6, 2005 |
Method of providing cosmetic/medical therapy
Abstract
A method for providing medical therapy treatment includes steps
for preparing an electrically activated substance, and for using
and applying the electrically activated substance internally to a
human or animal subject. The electrical activation process of the
substance includes making changes in a physical property thereof,
as demonstrated by the results.
Inventors: |
Orton, Kevin R.; (San
Clemente, CA) |
Correspondence
Address: |
ORRICK, HERRINGTON & SUTCLIFFE, LLP
IP PROSECUTION DEPARTMENT
4 PARK PLAZA
SUITE 1600
IRVINE
CA
92614-2558
US
|
Family ID: |
46281621 |
Appl. No.: |
11/133642 |
Filed: |
May 20, 2005 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
11133642 |
May 20, 2005 |
|
|
|
10307248 |
Nov 27, 2002 |
|
|
|
6920884 |
|
|
|
|
10307248 |
Nov 27, 2002 |
|
|
|
10211654 |
Aug 2, 2002 |
|
|
|
10211654 |
Aug 2, 2002 |
|
|
|
09919493 |
Jul 31, 2001 |
|
|
|
09919493 |
Jul 31, 2001 |
|
|
|
09289409 |
Apr 9, 1999 |
|
|
|
6488032 |
|
|
|
|
10307248 |
|
|
|
|
10207651 |
Jul 26, 2002 |
|
|
|
10207651 |
Jul 26, 2002 |
|
|
|
10032323 |
Oct 24, 2001 |
|
|
|
10032323 |
Oct 24, 2001 |
|
|
|
09670734 |
Sep 27, 2000 |
|
|
|
09670734 |
Sep 27, 2000 |
|
|
|
09259120 |
Feb 26, 1999 |
|
|
|
6181962 |
|
|
|
|
09259120 |
Feb 26, 1999 |
|
|
|
08865253 |
May 29, 1997 |
|
|
|
5885241 |
|
|
|
|
Current U.S.
Class: |
128/898 |
Current CPC
Class: |
A61N 1/32 20130101 |
Class at
Publication: |
128/898 |
International
Class: |
A61N 001/18 |
Claims
What is claimed is:
1. A method for preparing a substance for use as a medicament in
providing treatment to the body of a recipient, said method
including the steps of: placing an electrically conductive
substance in a container such that said electrically conductive
substance is separated from the body area of the recipient in need
of treatment; locating at least one pair of electrodes within the
electrically conductive substance of said container and spacing
said pair of electrodes from one another; connecting an alternating
current source to said at least one pair of electrodes and
operating said current source to generate alternating current
having a frequency lying in a range of frequencies between 10 KHz
and 1 MHz so that current flows through said electrically
conductive substance and between said electrodes for at least 10
minutes, and; removing said alternating current flow through said
electrically conductive substance.
Description
RELATED BACK INFORMATION
[0001] This application is a continuation of application Ser. No.
10/307,248 filed on Nov. 27, 2002.
[0002] application Ser. No. 10/307,248 is a continuation-in-part of
application Ser. No. 10/211,654, filed on Aug. 2, 2002, now
abandoned, which is a continuation of application Ser. No.
09/919,493, filed on Jul. 31, 2001, now abandoned, which is a
continuation of application Ser. No. 09/289,409, filed on Apr. 9,
1999, now U.S. Pat. No. 6,488,032.
[0003] application Ser. No. 10/307,248 is also a
continuation-in-part of application Ser. No. 10/207,651, filed on
Jul. 26, 2002, now abandoned, which is a continuation of
application Ser. No. 10/032,323, filed on Oct. 24, 2001, now
abandoned, which is a continuation of application Ser. No.
09/670,734, filed on Sep. 27, 2000, now abandoned, which is a
continuation of application Ser. No. 09/259,120, filed on Feb. 26,
1999, now U.S. Pat. No. 6,181,962, which is a continuation of
application Ser. No. 08/865,253, filed on May 29, 1997, now U.S.
Pat. No. 5,885,241. All of the aforementioned applications are
expressly incorporated herein by reference.
FIELD OF THE INVENTION
[0004] The present invention relates generally to providing
cosmetic/medical therapy and more particularly to a method of
preparing and using an electrically activated substance obtaining
advantagous qualities for use in such therapy.
BACKGROUND OF THE INVENTION
[0005] The use of transcutaneous electrotherapy to treat medicinal
conditions is known. Transcutaneous electrotherapy involves the
passage of an electrical current from one electrode to another,
such that the therapeutic current is caused to pass through a
target tissue of the patient. Some exemplary devices used in the
performance of transcutaneous electrotherapy are provided in U.S.
Pat. Nos. 397,474; 3,794,022; 4,180,079; 4,446,870; 5,058,605; in
French Patent 2621-827-A; and European Patent Application
EP-377-057-A.
[0006] Although the use of transcutaneous electrotherapy has been
around for a while, in many ways there are undesirable aspects. For
example, transcutaneous electrotherapy causes electrical current to
pass through the target tissue of the patient. Many patients may
find this unsettling, painful or otherwise undesirable.
Additionally, too much current, usually over about 1 milli-amp, can
also become uncomfortable, painful, and harmful to the patient.
Current also tends to concentrate near the electrodes or along
current paths, which is often not desirable when trying to control
the current density in tissue. In addition, the highly variable
impedance nature of tissue makes it difficult to try to determine
and repeat the proper treatment duration and settings.
[0007] In view of the foregoing, it is desirable to provide an
effective alternative to transcutaneous electrotherapy techniques
wherein electric current is not required to flow through the tissue
of the patient, which is also easier and simple to apply, can more
evenly distribute it's benefits, provide more accurate results, and
is more effective.
[0008] Other existing medical procedures, including such procedures
as surgical cut and lift, laser resurfacing, and chemical peels
damage the outer layers of skin, which must then be renewed. This
takes time, and there is risk of burning and scaring. Angioplasty
for treatment of coronary circulation impairments is expensive,
localized, and requires surgical techniques. Also, this procedure
is expensive, requires skilled professional administration, and
carries a certain degree of risk, as well as inconvenience, and
generally requires a healing period.
[0009] Various existing inhalants are available for relief of
symptoms of pulmonary conditions, but they often do not correct
them, as so consequently require continual usage.
[0010] Other existing medical drug therapy techniques have
limitations which may be undesirable. Drugs work by altering,
interfering with, supplementing or reacting in chemical means in
the body. As such, they may exhibit potent results, but will
generally require a variety of different compounds to provide a
useful range of therapies. There may also be side effects. Thus it
is desirable to provide a substance with drug like action, for use
in a medicinal way, that is relatively simple to make, simple in
structure, is easy to make and apply, has a wide range of uses,
more permanent results, can provide more effective results than
existing medications for many conditions, and does not cause
electrical current to directly flow through the tissue of the
recipient, whether a human or an animal. This invention provides
such a means.
SUMMARY OF THE INVENTION
[0011] The present invention provides a method for preparing a
substance or solution which has unique properties. Furthermore, the
substance or solution is uniquely adapted for simple, effective
use. The unique physical properties are particularly useful when
used in the manners described, and exhibit uniquely useful results.
More specifically, molecules of the substance are thought to be
forced to take on a random or unformed structure through the use of
disclosed electrical energy. A technique for initiating this
randomizing is disclosed. The spin, valence, structure, magnetic
coupling, or bonding of the atoms is likely affected. Also
disclosed is a technique for allowing very high current and energy
level concentrations to occur in a solution without instigating
electrolysis of the solution. Also disclosed are process time
parameters, and a technique for use of the solution.
[0012] The solution herein is generally termed "electrically
active".
[0013] One advantageous use of the electrically activated substance
herein is in the treatment of various diseases and biological
conditions. The electrically activated substance per this
disclosure is able to cause or trigger a molecular or chemical
action. The electrically activated substance disclosed tends to
exhibit catalyst type properties when injected in biological
tissue. That is to say, it tends to trigger pre-existing response
mechanisms in the tissue, rather than reacting with the in a direct
manner in the way a conventional drug would. Other existing medical
drug therapy techniques have limitations which may be undesirable.
Drugs work by altering, interfering with, supplementing or reacting
in chemical means in the body. As such, they may exhibit potent
results, but will generally require a variety of different
compounds to provide a useful range of therapies. There may also be
side effects. Thus it is desirable to provide a substance with drug
like action, for use in a medicinal way, that is relatively simple
to make, simple in structure, is easy to make and apply, has a wide
range of uses, more permanent results, can provide more effective
results than existing medications for many conditions, and does not
cause electrical current to directly flow through the tissue of the
recipient, whether a human or an animal. This invention provides
such a means.
[0014] According to one embodiment of the present invention, the
electrically activated substance herein largely comprises ordinary
tap water, or possibly distilled water. Although water has many
unusual properties, this invention is not necessarily limited to
using water as a base or component of the solution. Various other
compatible substances, particularly liquids, may potentially be
used for an activation solution. This might include various classes
of alchohols or other chemicals. Other existing medical drug
therapy techniques have limitations which may be undesirable. Drugs
work by altering, interfering with, supplementing or reacting in
chemical means in the body. As such, they may exhibit potent
results, but will generally require a variety of different
compounds to provide a useful range of therapies. There may also be
side effects. Thus it is desirable to provide a substance with drug
like action, for use in a medicinal way, that is relatively simple
to make, simple in structure, is easy to make and apply, has a wide
range of uses, more permanent results, can provide more effective
results than existing medications for many conditions, and does not
cause electrical current to directly flow through the tissue of the
recipient, whether a human or an animal. This invention provides
such a means.
[0015] Additional materials may be included or added to the
substance. In particular, placental, amniotic, serum, and stem cell
types of structures may be added, either before, during, or
especially after the application of the electrical signal. However,
the addition of these or any biological or living or post-living
cells are not an important or essential requirement for the
practice of this invention. Also vitamins, analgesics, and other
additives may be used.
[0016] In addition, other materials may be used or added to the
water or substance without departing from the spirit and scope of
the invention. For example, a thickening agent, such as PEG-150
Distearate or auramidopropyl beatine may be added to provide
thickening into a paste or gel or semi-solid consistency for easier
application, especially when using the substance topically.
[0017] One step of electrically activating the substance comprises
applying an electrical signal to the substance. The type of signals
used are important to obtaining useful results.
[0018] The use of an alternating or at least heavily pulsating
direct (DC) current is an important part of the invention. An
alternating current, and more particularly, a high frequency
alternating current (HFAC or just AC) has been found to be a
beneficial part in the process of re-structuring or randomizing the
molecules or activating the solution. This is enhanced by the flow
of electrons in both directions through the solution.
[0019] For example, on the +portion of the waveform, one electrode
is positive (+) and one electrode is negative (-). Current will
flow through the solution and, if electrically activating water,
hydrogen gas will evolve at one electrode, with oxygen at the
other. By reversing the polarity of the current flow (using an AC
waveform) on a periodic basis, the current flow will be reversed,
and the gasses evolved at each electrode will also reverse. A
direct current (DC) signal current does not initiate the activation
process.
[0020] In fact, a DC component in the signal will cause
electrolysis to occur, which is not a desired feature of this
invention. This invention does not rely on conventional
electrolysis of the solution to create its activation qualities.
With a DC component in the signal, there would be rapid production
of hydrogen and oxygen gas, and the substance will vaporize away in
a matter of minutes,--before sufficient activation occurs. There
will also be undesired changes in the PH level of the solution,
which is not necessary when practicing this invention.
[0021] When practicing the invention optimally, the PH balance of
the medium will not change substantially during the activation
process. This may be observed with a hand-held type digital PH
meter. A typical reading is 7.2 at the start of the activation
cycle, and a value of 7.1-7.3 at the end. (The electrical energy
should be removed when making a measurement.) Of course, if the PH
level should shift, as would occur with a non-symmetrical AC
waveform, the shift does not necessarily mean that the solution can
not be used.
[0022] The method of generating the electrical signals is known and
consists generally of a power source, a signal generator and a high
power amplifier.
[0023] Biological currents (electron transport functions) operate
at very small currents in mammals, on the order of nanoamps and
less, and so are easily overloaded at currents as small as about 1
milliamp. This limits the amount of excitation energy that is
useable with existing transcutaneous devices. However, if a large
amount of power is used on a bio-compatible material, new
beneficial properties are obtained.
[0024] In order to overcome the power limitation, a medium,
functioning as an intermediate transfer solution,--is employed.
Electrical signals are applied to the medium, which is then applied
to the patient after removal of current therethrough. In this way
more power may be used than would normally be comfortable or safe
for the patient if current were to flow through the patient.
[0025] In order to excite the solution adequately enough to become
activated, it is necessary to use a relatively large amount of
power. The minimum power density required is about 10 milliwatts
per milliliter. Thus, if a 100 milliliter (about 4 oz.) batch is
prepared, at least 1 watt and preferably 100 watts of power should
be used.
[0026] If a simple 60 hertz AC line waveform were used, it is not
possible to activate the solution. This is because at the high
power levels required, the solution exhibits strong electrolysis
action at low frequencies and the solution vaporizes away before
the solution can become sufficiently active.
[0027] In order to allow the solution to absorb high power levels
and yet prevent premature electrolysis of the solution, a specific
novel technique is employed. This comprises using an electrical
signal that preferably comprises an alternating current signal
operating in the frequency range of between approximately 10 KHz
and approximately 1 MHz, with between approximately 25 KHz and
approximately 100 KHz being optimum. When operating at the
specified frequency, the gassing away of the solution is reduced by
about 100 to 1000 times that of a lower frequency or DC signal.
There are also substantially more phase reversals of the current
flow per unit of time, and orders of magnitude more current and
power may be used. The electron agitation is also increased over
lower frequencies.
[0028] By switching the polarity of the current on a sufficiently
quick periodic basis, the atoms may be partially electrolyzed
(separated), yet recombined back together again before any gas
escapes. This partial electrolysis, current phase reversal, then
recombining and then re-separating again may be what contribute to
the substance becoming electrically activated. At this frequency,
the current reverses direction faster than molecules can be
atomized, broken up, and escape, and little gassing is released.
The new properties that the solution takes on at the specified
frequency and power levels then allow it to absorb significantly
more energy than at lower frequencies. In fact, the solution can
now absorb enough energy to cause electrical conduction heating of
the solution. This is the ideal condition for creating the
activated substance. The temperature rise of the substance during
activation will be approximately at least 3, 4, or 5 degrees and up
to approximately 100 degrees Fahrenheit above ambient, depending on
the actual power level used.
[0029] The frequency used is critical to the success of the device.
The substance will not become properly electrically activated if
the correct frequency is not used. The frequency range called for
is the one that allows the most bio-compatible activation. For
example, if a frequency of 60 hertz is used, the substance will
electrolyze away in only a few minutes at the power levels called
for in this invention. Additionally, the substance will just not
generate the biological response that frequencies in the range
specified will. At frequencies above about 1 Mhz, the present
medium will not take on the biological activation qualities,
although there may be other mediums which will respond at that
frequency. For example, applying microwave frequency energy to
water will not result in biologically active activation of the
substance. Thus the frequencies specified are found to work
best.
[0030] It is thought the current and frequency range of this
invention causes the molecules or atoms to become more fully
dissociated and unformed. This means groups of atoms or molecules
that normally gather together are broken apart into the smallest
possible units. They may also take on a random spin, where
electrons are not shared between atoms of a molecule in a familiar
and stabilized manner. The bonding levels may also be affected.
When partially separated molecules are reformed, the atomic
structure may take on slightly different formations in the presence
of the applied power. It is thought this random state reforming is
what makes the substance active.
[0031] Preferably, the alternating current has approximately
minimal direct current bias to prevent PH shift and gassing. In
order to mitigate direct current bias, the electrical signal is
preferably applied to the substance via a capacitor-resistor
network. Alternatively, the electrical signal is applied to the
substance via an isolation transformer.
[0032] The electrical signal preferably has a voltage of between
approximately 50 volts rms and approximately 150 volts rms.
[0033] The electrical signal is applied to the substance to be
electrically activated via at least one pair of electrodes. A
plurality of pairs of electrodes may be utilized, if desired. For
optimum results, the electrodes are comprised of an electrically
and biologically inert, non-reactive metal or a non-metallic
material having a low atomic number and low resistance. For
example, gold, carbon, and graphite-carbon material are suitable.
It has been found that lead, aluminum, copper, and other metals are
not recommended for the practice of this invention, as they can
cause lead ions, for example, to leach into the solution,
potentially poisoning the patient. Silver provides possible
antibiotic, antiseptic properties to the substance, and may
optionally be used or added to the substance when this is
desirable.
[0034] Additionally, multiple pairs of electrodes may be used with
various different phase relationships. In this case, it may not be
necessary for there to be minimal DC bias at all, as if one pair of
electrodes has a positive DC bias, and another pair has a negative
DC bias, the net charge bias into the solution may be near zero,
thereby effectively eliminating the undesired electrolysis
effect.
[0035] When distilled water is to be electrically activated, then a
substance must often be added to the water to introduce impurities
therein, so as to facilitate current flow therethrough.
[0036] According to one embodiment of the present invention, sodium
chloride (salt) or minerals are added to form an electrolyte from
distilled water.
[0037] According to the preferred embodiment of the present
invention, the additive substance, e.g., sodium chloride, is added
to the distilled water while monitoring current flow therethrough,
until the desired current is obtained. This process makes it easier
for the operator, and provides more consistent results.
[0038] According to a preferred embodiment of the present
invention, approximately 1 amp rms of current is caused to flow
through the substance to be electrically activated. Typically, a
voltage of approximately 100 volts rms is required to effect a
current of 1 amp rms. It has been found that currents as low as 1
milliamp may be used, if desired. Preferably, at least 10
milliwatts of power per milliliter of substance are utilized. When
a large amount of power is used in the activation process, new
beneficial properties are obtained.
[0039] Those skilled in the electrical art will appreciate that the
voltage required to effect the desired current is dependent upon
the conductivity of the substance being electrically activated.
[0040] Topical application of the electrically activated substance
of the present invention has been found to be effective in
mitigating wrinkles on human skin.
[0041] Additionally, the substance may be taken orally to obtain
additional benefits. When taken orally, approximately 2 ml of the
electrically activated substance is preferably ingested per day for
approximately 6 weeks.
[0042] Furthermore, the substance has also been found to provide
useful qualities for the treatment of internal conditions if
applied correctly.
[0043] These, as well as other advantages of the present invention
will be more apparent from the following description and
drawings.
BRIEF DESCRIPTION OF THE DRAWINGS
[0044] FIG. 1 shows apparatus including a variable frequency
current source being utilized to electrically activate a liquid
contained within a beaker;
[0045] FIGS. 2 and 3 are block diagrams showing alternate
configurations of the apparatus of FIG. 1;
[0046] FIG. 4 is a flow chart showing the steps involved in the
practice of the therapy method, according to the present
invention.
[0047] FIG. 5 illustrates one example of an alternating current
waveform at the output of the current source of FIG. 1.
[0048] FIGS. 6-8 and 13 illustrate the electrically activated
substance being applied to biological tissue.
[0049] FIGS. 9, 10, 11a-c, and 12a-b show tissue changes and
results obtained after the electrically activated substance has
been applied thereto.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT
[0050] The detailed description set forth below in connection with
the appended drawings is intended as description of the presently
preferred embodiment of the invention and is not intended to
represent the only form in which the present invention may be
constructed. The description sets forth the functions and the
sequence of steps for constructing and operating the invention in
connection with the illustrated embodiment. It is to be understood,
however, that the same or equivalent functions and sequences may be
accomplished by different embodiments that are also intended to be
encompassed within the spirit and scope of the invention.
[0051] The electrically activated substance and method for making
the same of the present invention are illustrated in FIGS. 1-13 of
the drawings which depict presently preferred embodiments
thereof.
[0052] Referring now to FIG. 1, a variable frequency current source
10 is electrically connected, via wires 12, to probes or electrodes
14 which are at least partially immersed within the substance 18 to
be electrically activated, which is contained within a beaker 16.
Alternatively, a fixed frequency current source may be used.
[0053] The variable frequency current source 10 preferably
generates an output with a frequency within the range of from
approximately 10 KHz to approximately 1 MHz, and a voltage output
from approximately 50 volts rms to 150 volts rms, and having a
maximum current output in excess of 1 amp rms, and provides
preferably a generally symmetrical alternating current
waveform.
[0054] According to the preferred embodiment of the present
invention, the variable frequency current source 10 also provides
an alternating current output having minimal direct current bias,
as illustrated in FIG. 5 of the drawings.
[0055] In order to re-structure the molecules in the solution
within the beaker 16, a high frequency alternating current (AC)
signal, preferably having a generally symmetric waveform, is
utilized. Thus, for example, referring to FIG. 5, a sinusoidal
waveform is suitable, as would be a square AC waveform, a
triangular AC waveform, or any odd-shaped AC waveform with
preferably equal energy in each polarity. A square wave generally
provides the highest power and best result. Those skilled in the
electrical art will appreciate that various other waveforms, both
symmetrical and non-symmetrical, would likewise provide alternating
flow of current. Additionally, various other combinations of
waveforms may likewise be suitable if they provide a beat or
resonance or modulation signal within the 10 Khz to 1 Mhz band.
[0056] According to the preferred embodiment of the present
invention, the frequency output of the variable frequency current
source 10 is capable of being swept or automatically varied between
a minimum and maximum frequency. Alternatively, the variable
frequency current source 10 is capable of being manually swept in
frequency.
[0057] The wires 12 preferably comprise copper wires having a
current rating sufficient to carry the required current, e.g., 1
amp rms, without excessive heating.
[0058] Typical dimensions for the electrodes 14 are 3 mm thick, 20
mm wide, and 10 cm long. However, as those skilled in the art will
appreciate, various different dimensions and cross-sectional
configurations, e.g., round, oval, square, triangular, etc., may
likewise be suitable.
[0059] Preferably, the electrical resistance of the finished
electrodes is less than 500 ohms/cm.sup.2, preferably less than 50
ohms/cm.sup.2.
[0060] Further, according to the preferred embodiment of the
present invention, the two electrodes are positioned several
centimeters apart in a 250 ml container, e.g., the beaker 16. The
beaker 16 is preferably formed of a non-conductive material, such
as glass or plastic. Thus, as described herein, the method for
electrically activating the substance 18 is preferably practiced
utilizing approximately 200 ml of the substance at a time. The
actual quantity of substance electrically activated may be varied
widely by varying the dimensions of the container, electrodes, and
by varying the strength of the electrical signal appropriately.
[0061] In one embodiment, current flow through the substance 18
being electrically activated is monitored as an electrolytic
substance is added thereto so as to form an electrolyte. For
example, when water is being electrically activated, then sodium
chloride is added to the water, so as to form an electrolyte. As
the sodium chloride is added to the water, current flow through the
water may be monitored until the desired current flow is achieved,
thereby indicating that sufficient sodium chloride has been added
to the water.
[0062] According to the preferred embodiment of the present
invention, approximately 1 amp rms of current is caused to flow
through the substance 18 being electrically activated while a
voltage of approximately 100 volts rms is applied thereto. Various
other voltage and amperage levels are likewise suitable.
[0063] Typically, current is allowed to flow through the substance
being electrically activated for approximately 4-8 hours. At this
point there will usually be small gas bubbles formed upon the
electrodes. At this point, the substance has been fully
electrically activated and is ready to use.
[0064] The degree to which the substance 18 is electrically
activated, and thus the effectiveness thereof, is directly related
to the voltage applied to the electrodes 14, the spacing of the
electrodes, the current caused to flow between the electrodes, and,
to some extent, the length of time that the current is applied. As
indicated in FIG. 4, current must flow between the electrodes for a
minimum of at least 10 minutes before any usable results are
typically obtained. It is thought that the application of current
for a time period in excess of 8 hours produces little additional
effectiveness of the electrically activated substance. The
recommended period of time is 4-12 hours.
[0065] The electrically activated substance is typically active for
only a limited amount of time after current flow therethrough has
ceased. The electrically activated substance is thought to be most
effective if utilized within approximately 4 hours after its
production. The electrically activated substance is thought to be
somewhat effective for up to 4 days after its production, and
almost totally diminished after 7 days. It is believed that the
decay in the effectiveness of the electrically activated substance
is logarithmic in nature, with more than half of the effectiveness
thereof lost within approximately 24 hours. Thus it is important to
use the substance promtly to derive the benefits described
herein.
[0066] The specified values for the applied voltage, duration, and
conductivity of the medium may be varied somewhat. Indeed, a
reduction in the effectiveness of the electrically activated
substance may be compensated for by varying one or the other of the
production parameters.
[0067] For example, a lower voltage may be utilized if additional
sodium chloride is added to the solution. However, if too much
sodium chloride is added, then the solution may become less
bio-compatible. Conversely, if less sodium chloride is utilized,
then a higher voltage is necessary to obtain sufficient current
flow through the substance. Inadequate current flow through the
substance results in substantially reduced effectiveness of the
electrically activated substance.
[0068] It is thought that the electrically activated substance of
the present invention, when applied to biological tissue, initiates
a weak electrical (or ionic) signal in the tissue, similar to the
alert signal that occurs when a mechanical strain to the tissue has
occurred. This is possibly caused by the spin, valence, or magnetic
coupling or polarizing activity of the activated substance. The
activated substance may possibly work by loosening weak molecular
bonds in the tissue, thereby causing a regeneration response as the
bonds or tissues recover. The activity of the substance triggers
accelerated metabolic activity in the treatment area. Blood flow
accelerates while cellular metabolic activity and interactions
increase. As is best shown in FIGS. 9 and 10, capillaries and/or
blood vessels 50 dilate following the treatment and there is
increased cellular activity. Toxins, free radicals, metabolic waste
and remnant material may be re-formed or flushed away.
[0069] The electrically activated substance of the present
invention need not be applied to fresh injury sites. It may
interfere with the timing and development of the natural current of
injury, thereby inhibiting the healing process. However, once the
injury has stabilized, the electrically activated substance of the
present invention may be applied thereto so as to enhance or
re-stimulate the healing process.
[0070] One use of the electrically activated substance of the
present invention is the treatment of skin sagging. Preferably, the
water is activated with a frequency of between approximately 50 KHz
and 100 KHz. When injected for this purpose, there is a uniform
reduction of sagging througout the body.
[0071] After each application, the recovery phase typically has a
duration of approximately 1 to 7 days. After about 4 days, most of
such recovery has occurred. At the end of the recovery phase,
another treatment may be applied. It has been found that the
recovery phase must be complete before a subsequent treatment, so
as to avoid overwhelming the response mechanism.
[0072] It has been found that approximately three to six such
treatment sessions are typically required for maximum results. One
session every one to two weeks. The more degenerated the tissue,
the more dramatic the results are. The substance also exihibits
strong antiviral properties. The general result is renewed
appearance, without surgery, grafting, patchwork, dermabrasion,
laser vaporization, or other invasive or mechanical techniques.
Additionally, electric current is never caused to pass through
living tissue or cells directly.
[0073] In addition to being used to treat wrinkles, the substance
may also be advantageousely used to treat pulmonary conditions.
This is shown in FIG. 6. The electrically activated substance 18 is
inhaled as a mist, or droplet form. This is preferably accomplished
with the use of a conventional nebulizer 74 to convert the liquid
to a vaporous material 72.
[0074] Such nebulizers are commercially available through various
health care providers. Some models use compressed air or mechanical
vibrations to convert a liquid or fluid to a fine mist. One such
device is sold under the trademark "Micro Air" by Omron Industries.
This device breaks the liquid into small particles from
approximately 1 micron to 10 microns in size. These particles are
clumps of molecules. When the substance is converted to a vaporous
mist 72 in this manner, the electrically activated properties of
the substance are found to remain. When the electrically activated
substance 72 is inhaled, additional advantages and benefits to the
recipient are realized. For example, when inhaled as a mist, the
substance may be used to beneficially treat lung and pulmonary
tract problems and disorders.
[0075] That is, pulmonary fibrosis, some types of emphysema, and
other conditions may be treated in this manner. Interstitial
fibrosis occurs when lung tissue becomes scarred and looses its
flexibility and elasticity. This can happen after an infection, for
example, or contact with an irritant and can make breathing
difficult and even painful. There may also be a loss of capillary
and blood-gas (air) exchange function. This condition can be
improved when the vaporous mist 72 is inhaled.
[0076] FIG. 12a shows a cutaway patch of pulmonary fibrosis tissue
90. The tissue 90 is largely composed of fibrous strands 91. There
are a lack of blood vessels, and the tissue is stiff. FIG. 12b
shows the same portion of tissue 90 after coming into contact with
the vaporous mist 72 of FIG. 6. The mist 72 helps to soften and
diminish the fibrous tissue 91 and generate new blood vessels 92,
thereby helping to restore normal capillary action and lung
function.
[0077] Emphysema occurs when air sacs (aveoli) in the lungs burst.
This is the result of weakened connective tissue. It is often
initiated by air pollutants. The active-energy properties of the
substance of this invention acts to improve the condition of the
connective tissue and dislodge and remove contaminants. In this way
further destruction is minimized and even some function
restored.
[0078] Arterial plaque is another condition which is desirous to
treat. This is a commonly occurring condition. It is partly
influenced by diet. The plaque is largely composed of fats and
lipids which have not been metabolized. These fatty deposits become
attached to artery walls and surfaces and can build up over a
period of time. These same fatty deposits may also build up in
other tissues throughout the body. If the buildup continues, the
plaque can reduce the size of arterial passageways, thereby
inhibiting blood flow and impairing chemical function and activity.
The fatty deposits may also accumulate in the body in general.
[0079] This is shown in FIG. 11a. The cross sectional view of an
artery 122 has a build up 121 on the interior lining 123 which
constricts its size, reducing the flow of blood therethrough.
[0080] The activated substance of the invention, when prepared as
described herein, has been found to posses unique capabilities
resulting in an effective and useful technique of treating such a
plaque condition when the substance is injected into the blood
stream. A syringe, catheter, or other such type of device may be
used to effect the internal injection. This is shown in FIG. 7. A
hypodermic needle 71 is attached to a syringe 73 or a container
containing the electrically activated substance 18. The needle 71
is inserted through the epidermal layers of skin in order to inject
the substance 18. In FIG. 8, an I.V. feed may also be used. A
hypodermic needle 71 is attached to a tube 75 and a container 77
containing the electrically activated substance 18. The needle 71
is inserted through the epidermal layers of skin in order to inject
the liquid 18.
[0081] FIG. 11b shows the artery 122 of FIG. 11a with the activated
substance 18 contacting the blood 124 and the plaque 121. FIG. 11c
shows the same artery 122 with the plaque 121 diminished in size
after the treatment.
[0082] FIG. 13 shows a hypodermic needle 81 connected to a syringe
82 that carries the activated substance to be injected through the
skin of an animal.
[0083] Graduation marks on the syringe 73 or the IV container 77
measure the amount of activated liquid 18 to be applied in a dose.
When injected, the typical dose rate is one to two cc's per 100
pounds of body weight.
[0084] When injected in this way, blood flow and metabolic activity
accelerates and increases beginning about 15 minutes after the
injection. There will begin a flushing action in the tissue. The
heart will beat stronger. There may be a very slight fever. There
is a slight tingling sensation, but no pain. This will last 1-2
days. After this period of accelerated blood flow, the body enters
a recovery phase wherein the cellular structure thereof is
rebuilt.
[0085] When taken internally as an injection or IV into the blood
stream, the molecular action of the electrically activated
substance then becomes useful to dissolve, solubolize, loosen and
remove fatty deposits and plaque buildup from the artery walls.
This increases capillary and general blood flow and action. When
the fatty deposits which commonly occur in the blood vessels and
throughout the body and blood flow system are cleaned away and
solubolized as described herein, the chemical and metabolic
efficiency and effectiveness of the body therafter increases
greatly, causing significant and substantial improvements in the
functioning, operation, and regeneration ability of most all body
systems and processes. This will then allow the strengthening of
arterial walls and improve the production of collagen and ligament
type support structures. Thus the method provides a new, useful and
effective treatment for plauqe build up conditions and positive
additional benefits. The process thus also serves to provide pain
relief to the recipient.
[0086] There are minimal other outward signs during treatment,
however the skin may become temporarily wrinkled. The wrinkling is
caused by the skin drawing together on the inside of the body,
resulting in bunching up on the outside. This fades away after a
while. After the first treatment, and particularly after 3-6
treatments 1 week apart, facial characteristics are smoothed and
sagging features become lifted.
[0087] Other typical uses for the substance when injected are for
the treatment of internal organs in general, as well as the blood
and circulation system, and other textbook medical/cosmetic
conditions, and is applicable to both humans and animals.
[0088] When used as an internal injection or IV, the substance is
often best administered several times over a period of weeks or
months. The first few treatments may be at a lower dosage rate to
avoid an excessively strong reaction the first time the product is
used.
[0089] Although an exemplary technique has been disclosed, there
are other acceptable means of injecting the electrically activated
substance into the body. It may also be applied with somewhat
effectiveness as a douche or applied through the use of various
tubes and with other devices without departing from the spirit and
scope of the invention.
[0090] The substance may also be inhaled or injected along with
other materials, nutrients, and drugs, without departing from the
scope of this invention.
[0091] Because the electrically activated substance of the present
invention functions as a transfer agent or medium, there is no
current flow from the current source through biological tissue.
Thus, there is no chance of burns, thereby enhancing the safety of
such treatment. Further, there is no muscle contraction or nerve
impulse firing as a result of using the electrically activated
substance of the present invention, as is common during
contemporary transcutaneous electrotherapy. Furthermore, there is
substantially no removal of tissue, unlike dermabrasion and other
techniques, and no acid/base effects on the body from PH
shifts.
[0092] Although several uses have been described, there are of
course many other medical conditions in both humans and animals
which may respond favorably in this manner. For example, the
substance has been found to have strong anti-viral properties, and
may be used by itself or with other drugs, as well as for generally
treating pain. The substance is also useful in treating and
repairing conditions associated with damaged and cross-linked
protein structures.
[0093] Referring now to FIGS. 2 and 3, if the variable frequency
current source 10 does not provide approximately 0 direct current
bias, then the output thereof can be processed so as to mitigate
direct current bias.
[0094] With particular reference to FIG. 2, a resistor-capacitor
network 22 may be used to filter the output of the variable
frequency current source 10, so as to mitigate direct current bias.
Such a resistor-capacitor network comprises at least one capacitor
26 in series with the substance 18 being electrically activated and
at least one resistor 28 in parallel therewith. The
resistor-capacitor network 22 functions according to known
principles to mitigate the presence of DC bias in the substance
being electrically charged. Those skilled in the art will
appreciate that various other types of filters may be utilized. For
example, a capacitor inductor network may be utilized.
[0095] With particular reference to FIG. 3, an isolation
transformer 24 isolates the substance 18 to be electrically charged
from direct current bias present in the output of the variable
frequency current source 10.
[0096] In any instance, when the variable frequency current source
10 does not include a means for monitoring current flow through the
substance 18 being electrically activated, then such means is
preferably included in the electrical path of the electrodes 14.
For example, an amp meter 20 may be inserted in line or applied
inductively to one of the wires 12 which provide an electrical
pathway for the current which travels between the electrodes 14.
Alternatively, an oscilloscope may be utilized to monitor current
flow and voltage between the electrodes 14.
[0097] Referring now to FIG. 4, the method for forming the
electrically activated substance 18 of the present invention
generally comprises the step 30 of providing distilled water, the
step 32 of adding sodium chloride to the distilled water while
monitoring current flow between the electrodes 14, the step 34 of
applying alternating current to the electrodes 14 and the step 36
of administering the electrically activated substance, preferably
within four hours after the electrical activation thereof.
[0098] The electrically activated substance is only administered
after first discontinuing the application of current thereto. In
this manner, the electric current can be applied to an intermediate
material, (i.e., the electrically activated substance), rather than
directly to a person. Thus, a substantial amount of power may be
applied to the electrically activated substance, without
undesirable interference with biological processes which would
occur if an electrical signal of strong energy were applied
directly to a recipient. Indeed, according to the preferred
embodiment of the present invention, much more power, (for example
100 watts), can be applied to the electrically activated substance
than could comfortably be tolerated by human tissues.
[0099] The minimum amount of power applied to the substance during
electrical activation thereof must be sufficient to overcome the
activation decay rate of the substance. A small activation energy
will disperse as quickly as it is generating, prohibiting adequate
activation of the substance. It has been found that the application
of at least approximately 10 milliwatts of electrical power, and
preferably 100-400 milliwatts, per milliliter of substance results
in an acceptable decay rate.
[0100] Non-distilled or tap water or other bio-compatible
compounds, including tissue products, may be utilized instead of
distilled water. It has been found that tap water is frequently
suitable for use in the practice of the present invention. However,
as those skilled in the art will appreciate, the types and amounts
of impurities found in tap water vary considerably from one
location to another. Thus, if an accurate analysis of the tap water
to be utilized is not available, then the effectiveness and current
flow therethrough may be determined by trial and error.
[0101] Various other electrolyte forming substances, other than
sodium chloride, are likewise suitable including but not limited to
potassium, salts, and minerals.
[0102] The application of alternating current during step 34 to the
substance to be electrically activated preferably takes place for a
duration of approximately 4 to 8 hours. After this amount of time,
there may be small gas bubbles on the electrodes.
[0103] The electrically activated substance is created using the
power levels, frequencies, current densities, and dosage quantities
described herein, or parameters comparable to those described
herein. When the substance is produced in this manner, it takes on
unique properties.
[0104] The electrically activated substance is created using the
power levels, frequencies, current densities, and dosage quantities
described herein, or parameters comparable to those described
herein. When the substance is produced in this manner, it takes on
unique properties (possibly on an atomic level), which make it
particularly well suited for the practice of the present
invention.
[0105] It is understood that the exemplary methods described herein
and shown in the drawings represents only a presently preferred
embodiment of the invention. Indeed, various modifications and
additions may be made to such embodiment without departing from the
spirit and scope of the invention. For example, various different
sizes, shapes, and configurations of the container, the electrodes,
and the source and type of alternating current are contemplated.
Further, the use of water as the electrically activated substance
is by way of example only, not by way of limitation. Indeed, it is
also anticipated that gases, as well as liquids and conductive
solids may be electrically activated according to the techniques of
the present invention.
[0106] Thus the invention provides a new and useful therapy.
[0107] These and other modifications may be adapted to the present
invention in keeping with the original spirit and scope of the
invention.
* * * * *